In this preliminary randomized study, we have measured pain scores at rest and on movement, 24 and 48 h after operation in 19 control patients, who received 50 ml of saline i.p., and in 20 test patients, in whom 50 ml of saline solution containing lignocaine 200 mg and adrenaline 1:500 000 were instilled into the peritoneal cavity after total abdominal hysterectomy. We found that there was no difference in linear analogue scores for nausea, pain on movement or morphine consumption after operation between the two groups, but pain scores at rest were significantly lower in the lignocaine group at 24 and 48 h compared with the saline group. In the lignocaine group, blood sampling over a 3-h period revealed a mean maximum serum concentration of 0.4 g ml 
Recently, there has been interest in the instillation of local anaesthetic solutions into the peritoneal cavity for treatment of pain after abdominal surgery. This technique has been described as producing effective analgesia after laparoscopic cholecystectomy by some workers [1] [2] but not by others. 3 After gynaecological laparoscopy, there is stronger evidence for effective analgesia. [4] [5] [6] [7] Serum concentrations of local anaesthetics have been measured after i.p. administration of lignocaine and bupivacaine during gynaecological laparoscopy and the authors concluded that the use of a plain solution of lignocaine led to relatively high but safe serum concentrations of the drug with a dose of 400 mg. The addition of adrenaline was shown to produce a substantial reduction in the maximum serum concentrations attained. 8 We were interested to see if i.p. instillation of local anaesthetic produced effective analgesia after total abdominal hysterectomy. Because of the greater degree of trauma after hysterectomy than after laparoscopy, we were concerned that the rate of absorption of local anaesthetic might be faster after hysterectomy. Consequently, we devised a study to assess serum concentrations of lignocaine after instillation of a relatively small dose (200 mg) of lignocaine into the peritoneal cavity and, at the same time, examine the effect on postoperative analgesia to serve as a guide to a subsequent study designed to assess the analgesic efficacy of larger doses of local anaesthetic solutions.
Patients and methods
After obtaining approval from the Leicestershire Ethics Committee and written informed patient consent, we studied 40 patients undergoing total abdominal hysterectomy. All patients were aged 20-60 yr, ASA grade I or II, not undergoing surgery for malignancy and were scheduled for surgery undertaken via a standard Pfannenstiel incision. Patients were excluded if they had cardiac or vascular disease, hepatic disease, allergy to local anaesthetic agents or any contraindications to local anaesthesia.
Anaesthesia was standardized and comprised premedication with temazepam 10 mg, induction with propofol 150-200 mg, intubation of the trachea and controlled ventilation of the lungs using 1.5-2.0% enflurane and 66% nitrous oxide in oxygen. Vecuronium was given as required to produce neuromuscular block and a standard dose of morphine 10 mg (combined with prochlorperazine 12.5 mg) was given shortly after induction of anaesthesia to provide analgesia in the immediate postoperative period. After induction of anaesthesia, a second cannula was inserted into the contralateral antecubital fossa from the arm in which the i.v. infusion was sited and 10-ml samples of venous blood were obtained before and at 1, 3, 5, 10, 15, 20, 30, 60, 120 and 180 min after instillation of local anaesthetic into the peritoneal cavity. After administration of morphine, patients were allocated randomly using sealed envelopes and random numbers generated by computer to receive either local anaesthetic solution or an equal volume of saline solution. The local anaesthetic solution comprised 50 ml of 0.4% lignocaine with adrenaline (1:500 000 dilution) prepared by adding 30 ml of saline to 20 ml of 1% lignocaine containing adrenaline 1:200 000. 
British Journal of Anaesthesia
Total abdominal hysterectomy was carried out using a standard technique by one of four surgeons, the majority being performed by a single surgeon. The peritoneum over the vault of the vagina was not closed and the local anaesthetic or saline solution was instilled into the pelvic cavity only after haemostasia had been secured, all packs removed from the peritoneal cavity and the patient placed in the supine horizontal position.
After operation, patients were provided with patient-controlled analgesia equipment (Abbott PCA II; morphine 1-mg boluses with 8-min lockout), the use of which had been explained in detail at the preoperative assessment. This technique is used routinely and supervised by the sister in the acute pain service at Leicester Royal Infirmary. The patient and pain sister, who acted as an observer, the recovery room staff, surgical staff and the nursing staff on the ward were blinded to the nature of the solution administered into the peritoneal cavity. In our hospital, the pain sister is allowed to give bolus doses of morphine up to 5 mg i.v. in the recovery room in order to provide optimal analgesia immediately after recovery.
In the postoperative period, the patient completed linear analogue pain scores, at 24 and 48 h, for pain at rest and during a standardized movement (sitting upright from the supine horizontal position). In addition, she completed linear analogue scores for nausea and sedation. 8 Serum concentrations of lignocaine were measured using high pressure liquid chromatography and ultraviolet detection. The intra-assay coefficient of variation was 3.6% and the inter-assay coefficient of variation was 4.2%. The limit of detection was 0.04 g ml 91 .
Data were analysed using SPSS version 6.0 for Windows running on an IBM compatible PC and serum concentrations of lignocaine were plotted using Graphpad Prism version 2.0. Data were subjected first to Komolgorov-Smirnov goodness of fit tests for normality of distribution. All data were found to be distributed normally and were therefore compared using the Student's t test. P:0.05 was taken as significant. Because of concern about the normality of distribution of linear analogue scores, data were analysed also by Mann-Whitney U tests.
Results
Data from one patient in the saline group were rejected because of failure of standardization of the anaesthetic technique. Thus we have compared data from 19 patients in the saline group with 20 in the lignocaine group. The two groups were comparable in age and duration of anaesthesia (table 1) . Cumulative morphine consumption (total given in the intraoperative period, in the recovery room and by PCA) in the first 24 and 48 h was the same in both groups and the mean number of injections of prochlorperazine to control vomiting was the same also in both groups. There was no difference between the two groups in the bolus dose of morphine given by the pain sister in the recovery room. In the saline group, there was a total of 11 episodes of vomiting (number of individual retchings or vomits) in seven patients and in the lignocaine group a total of nine episodes of vomiting in six patients, all within the first 24 h.
After operation, there was a small but significant difference in linear analogue pain scores both at 24 and 48 h for patients at rest; the lignocaine group reported significantly less pain than the saline group (P:0.05 using Student's t tests and also the Mann-Whitney U test). Although there was also less pain reported on movement in the lignocaine group, this was not significantly different from that in the saline group. There were no significant differences between the two groups in linear analogue scores for nausea or sedation (data not shown).
Lignocaine was absorbed rapidly from the peritoneal cavity; serum concentrations reached a plateau by approximately 5 min after instillation into the pelvic cavity. Thereafter, plasma lignocaine concentration tended to increase very slowly and to a very slight extent for the duration of sampling over 3 h ( fig. 1) . The final mean maximum concentration achieved at 3 h was approximately 0.4 g ml
91
. The highest concentration observed at any time in any patient was 0.87 g ml
. 
Discussion
We have found that instillation of a relatively small dose of lignocaine (200 mg) into the pelvic cavity before closure of a Pfannenstiel incision after total abdominal hysterectomy was associated with lower pain scores at rest, at 24 h and at 48 h after operation compared with a control group given saline; however, only data for pain at rest were statistically significant. In every other respect, the two groups of patients behaved in a similar manner, with the same degree of postoperative emesis, same requirements for antiemetics and similar consumptions of morphine by PCA over the 48-h period after operation. There was no morbidity associated with instillation of solutions into the peritoneal cavity and there was no morbidity or mortality in the patients examined in this study. We found that lignocaine was absorbed relatively rapidly from the peritoneal cavity reaching approximately 0.25 g ml 91 by 5 min, but subsequently there was a slow gradual increase up to approximately 0.4 g ml 91 by 3 h after instillation. Narchi and colleagues 8 found that, after gynaecological laparoscopy, the rate of absorption of lignocaine from the peritoneal cavity was relatively slow; the time to maximum concentration (tC P max) was reached at 29 min with plain lignocaine 400 mg, at 58 min using lignocaine 400 mg with adrenaline 1:320 000 and at 72 min with lignocaine 400 mg and adrenaline 1:800 000. In both Narchi's study and ours, the maximum concentration of lignocaine attained (C P max) was relatively low. Narchi and colleagues found a C P max value of 4.3 g ml 91 with plain lignocaine 400 mg, 2.3 g ml 91 with lignocaine 400 mg and adrenaline 1:320 000, and 1.89 g ml 91 using lignocaine 400 mg with adrenaline 1:800 000.
We used half the dose of lignocaine that Narchi and colleagues used. Our data suggest that if we had used lignocaine 400 mg with adrenaline, we would have found a C P max value of 0.8 g ml 91 which is one-third of the C P max found in that study; this suggests that the rate of absorption of lignocaine was slower after hysterectomy than after gynaecological laparoscopy.
The serum concentration of lignocaine at which toxic symptoms begin to occur is approximately 3 g ml 91 in the unmedicated subject but the threshold increases in patients during anaesthesia. 9 Thus our data suggest that a dose of lignocaine 400 mg would be extremely unlikely to result in toxicity when given into the pelvic cavity after abdominal hysterectomy.
In summary, we have found that administration of lignocaine 200 mg into the peritoneal cavity after total abdominal hysterectomy was associated with low serum concentrations of lignocaine and that it should be possible to administer a larger dose of 400 mg without fear of approaching toxic concentrations. Furthermore, we have obtained some evidence that lignocaine 200 mg was associated with a measurable analgesic effect, although of modest clinical magnitude. Thus this preliminary study suggests that the technique is safe, and that it is worthwhile examining the use of larger doses of lignocaine and also bupivacaine for analgesia after total abdominal hysterectomy.
